Duchenne Muscular Dystrophy in Jordan
How patients in Jordan access treatment for duchenne muscular dystrophy via Named Patient Program.
About Duchenne Muscular Dystrophy
Neuromuscular
Treatment access in Jordan
Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.
For patients in Jordan with duchenne muscular dystrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with duchenne muscular dystrophy in Jordan
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Jordan and confirm US supply.
- Treating physician in Jordan issues prescription and justification.
- We file Jordan-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Jordan.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.